Latest Lead News

TG Metals Limited has raised $2.6 million through a placement to accelerate exploration and development at its Van Gold Uden deposit and Gold City prospect in Western Australia.

Adherium Limited has raised A$0.35 million through an institutional placement, supplementing its recent entitlement offer to strengthen its financial position and support growth initiatives.

Canyon Resources has drawn down US$26 million from its US$140 million credit facility to accelerate infrastructure and rolling stock procurement at its Minim Martap bauxite project, targeting production start in early 2026.

Enova Mining has raised $0.85 million to fund a diamond drilling campaign targeting high-grade rare earth elements at its East Salinas Project in Brazil, signaling strong investor confidence and advancing its critical minerals portfolio.

Stavely Minerals has raised A$1.9 million through a placement to fund drilling at its promising gold prospects, including Fairview North and South. The move aims to accelerate exploration and deliver new insights later this year.

Activeport Group Ltd has announced a fully underwritten rights issue to raise up to $2.5 million, offering shareholders discounted shares and free options to accelerate growth initiatives.

Rhythm Biosciences has advanced its ColoSTAT® diagnostic kits to final production validation, demonstrating consistent detection of colorectal cancer across all stages in a pivotal study. The company is gearing up for regulatory submission and commercial launch later this year.

Augustus Minerals has appointed Dr James Warren as its new CEO, bringing a wealth of exploration and corporate growth experience to lead its promising Western Australian projects. This leadership change signals a strategic push towards advancing drilling campaigns and unlocking shareholder value.

Nimy Resources has identified a significant copper-zinc-gold anomaly at its Sneaky Squirrel Gossan Prospect within the Mons Project, Western Australia, hinting at a potential volcanogenic massive sulphide deposit similar to Golden Grove.

Nyrada Inc. has raised $8.25 million through a strategic placement to fund its upcoming Phase IIa clinical trial of Xolatryp for acute myocardial infarction, positioning the company for a pivotal year ahead.

Antilles Gold Limited has had its trading suspension lifted on the ASX following the release of its quarterly activity and cash flow reports for June 2025, reopening the stock to market activity.

NIMY Resources has reported exceptional high-grade gallium assay results from its Block 3 prospect within the Mons Project, positioning itself as a key player amid global supply constraints driven by China's export ban.